Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA exonuclease 4 (REXO4) is an enzyme found in humans that has 3'-5' exonuclease activity, enabling the degradation of nucleic acids from the 3' end[1][2][7]. It binds DNA and RNA and is involved in both DNA and RNA catabolic processes as well as DNA repair[2][4][6]. REXO4 is predominantly located in the nuclear speck and nucleolus[2][6]. Its activity suggests potential roles in ribosome biosynthesis and genome stability maintenance, and it is considered essential for the normal processing of nucleic acids in the cell[1][2][3][7]. There is no evidence at this time that it serves as a direct therapeutic target or is associated with approved drugs, nor are safety concerns or biomarker roles established in current literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA exonuclease 4 (REXO4).